Promising new biomarkers in DKD are urinary neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, serum cystatin C, uromodulin, urinary N-acetylo-beta-D-glucosaminidase, the liver-type fatty acid binding protein, and serum interleukin 18 [40]. The gene discussed is LCN2; the disease is diabetic kidney disease.